about
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr ...
Read More
2.02
0.41
(25.47%)
4.5M
XNAS Volume
High volume+gain today
XNAS 06 Mar, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Pulmonx Corp is on 11 Mar 2026 for the purpose of Pulmonx Corp Annual Report for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Pulmonx Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..